Advertisement

Topics

New England Journal of Medicine Publishes Novavax' NanoFlu Clinical Trial Data

19:10 EDT 13 Jun 2018 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
NanoFluTM Phase 1/2 trial data published in a peer-reviewed letter to the editor in The New England Journal of Medicine NanoFlu demonstrates significantly improved immune responses against a panel of homologous and drifted A(H3N2) influenza viruse...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "New England Journal of Medicine Publishes Novavax' NanoFlu Clinical Trial Data"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Influenza
Influenza or 'flu' is a respiratory illness associated with infection by influenza virus. Symptoms frequently include headache, fever, cough, sore throat, aching muscles and joints. There is a wide spectrum of severity of illness ranging from min...

Vaccines
A vaccine is any preparation intended to produce immunity to a disease by stimulating the production of antibodies. It creates immunity but does not cause the disease. There are several differnt types of vaccine avalable; Killed microorganisms; which s...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...